Kaihang
Xue
a,
Feng
Wei
d,
Jinyan
Lin
*ab,
Haina
Tian
a,
Fukai
Zhu
a,
Yang
Li
*ce and
Zhenqing
Hou
a
aDepartment of Biomaterials, College of Materials, Research Center of Biomedical Engineering of Xiamen & Key Laboratory of Biomedical Engineering of Fujian Province, Xiamen University, Xiamen 361005, P. R. China. E-mail: linjinyan1988@163.com
bThe United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, P. R. China
cCAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, P. R. China. E-mail: liyang@xmu.edu.cn
dNeurosurgical Department of Affiliated Zhongshan Hospital, Xiamen University, Xiamen 361004, P. R. China
eDepartment of Translational Medicine, Xiamen Institute of Rare Earth Materials, Chinese Academy of Sciences, Xiamen 361024, P. R. China
First published on 7th January 2021
Correction for ‘Tumor acidity-responsive carrier-free nanodrugs based on targeting activation via ICG-templated assembly for NIR-II imaging-guided photothermal-chemotherapy’ by Kaihang Xue et al., Biomater. Sci., 2021, DOI: 10.1039/D0BM01864C.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2021 |